durapatite has been researched along with etidronate in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (18.18) | 18.7374 |
| 1990's | 7 (31.82) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Avioli, LV; Carano, A; Jeffrey, JJ; Malone, JD; McCracken, R; Pacifici, R; Rifas, L; Santoro, SA | 1 |
| Arends, J; Christoffersen, J; Christoffersen, MR; Ruben, J | 1 |
| Abe, K; Hidaka, S; Liu, SY | 1 |
| Pearce, EI; Vintiner, GM | 1 |
| Register, TC; Wuthier, RE | 1 |
| Harless, JD; Wefel, JS | 1 |
| Sallis, JD; Williams, G | 1 |
| Brown, MR; Sallis, JD; Shankar, R; Wong, LK | 1 |
| Hidaka, S; Okamoto, Y | 1 |
| Hyvönen, PM; Kowolik, MJ | 1 |
| Breuer, E; Golomb, G; Klenner, T; Krempien, B; Mönkkönen, J; Ornoy, A; Patlas, N; Schlossman, A; Similä, J; Stadler, H; Van Gelder, JM | 1 |
| Baron, R; Coxon, F; Dunford, JE; Ebetino, FH; Kashemirov, BA; Marma, MS; McKenna, CE; Russell, RG; Stewart, C; Triffitt, JT; Xia, Z | 1 |
| El-Mabhouh, AA; Mercer, JR | 1 |
| Hashimoto, K; Hidaka, S; Ishiyama, K; Okamoto, Y | 1 |
| Ito, M; Mihara, M; Miyabe, S; Nakano, T; Shiraishi, A; Umakoshi, Y | 1 |
| Barnett, BL; Dunford, JE; Ebetino, FH; Lawson, MA; Locklin, RM; Phipps, RJ; Russell, RG; Triffitt, JT; Xia, Z | 1 |
| Henry, C; Jahnke, W | 1 |
| Bhat, MR; Khajuria, DK; Mahapatra, DR; Mariappan, L; Rao, RR; Razdan, R; Sahana, H; Suresh, S | 1 |
| Beekman, FJ; Bloemendal, HJ; de Klerk, JMH; Hendrikse, NH; Lange, R; Ramakers, RM; Ter Heine, R; van der Westerlaken, MML | 1 |
| Nikfar, Z; Shariatinia, Z | 1 |
| Busquets-Cortés, C; Calvo, P; Costa-Bauzá, A; Grases, F; López-González, ÁA; Riutord, P; Sanchis, P | 1 |
| Chen, C; Cherian, P; Ebetino, FH; Hu, E; Junka, AF; McKenna, CE; Neighbors, J; Pawlak, J; Roshandel, S; Russell, RGG; Sedghizadeh, PP; Sodagar, E; Sun, S; Tjokro, N | 1 |
22 other study(ies) available for durapatite and etidronate
| Article | Year |
|---|---|
Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells.
Topics: Animals; Antibodies, Monoclonal; Bone Matrix; Bone Resorption; Cell Adhesion; Cells, Cultured; Collagen; Durapatite; Etidronic Acid; Guinea Pigs; Humans; Hydroxyapatites; Interleukin-1; Leukocytes, Mononuclear; Polymyxin B; Rats; Receptors, Cell Surface; Receptors, Collagen | 1991 |
The effect of EHDP concentration on enamel demineralization in vitro.
Topics: Animals; Calcium; Cariostatic Agents; Cattle; Dental Caries; Dental Enamel; Dental Enamel Solubility; Durapatite; Etidronic Acid; Hydrogen-Ion Concentration; Hydroxyapatites; Time Factors | 1991 |
A new method for the study of the formation and transformation of calcium phosphate precipitates: effects of several chemical agents and Chinese folk medicines.
Topics: Adenosine Triphosphate; Calcium Phosphates; Caseins; Chondroitin Sulfates; Crystallization; Diphosphates; Dodecanol; Drugs, Chinese Herbal; Durapatite; Egtazic Acid; Etidronic Acid; Hydrogen-Ion Concentration; Hydroxyapatites; Magnesium; Phosphatidylserines; Serum Albumin, Bovine; Sodium Dodecyl Sulfate; Spectrophotometry, Atomic; Strontium; X-Ray Diffraction | 1991 |
Effect of monofluorophosphate on calcium phosphate formation in supersaturated solutions.
Topics: Calcium; Calcium Phosphates; Chemical Phenomena; Chemistry, Physical; Crystallization; Crystallography; Diphosphates; Durapatite; Etidronic Acid; Fluorides; Hydrogen-Ion Concentration; Hydroxyapatites; Phosphates; Spectrophotometry, Atomic; X-Ray Diffraction | 1990 |
Effect of pyrophosphate and two diphosphonates on 45Ca and 32Pi uptake and mineralization by matrix vesicle-enriched fractions and by hydroxyapatite.
Topics: Alkaline Phosphatase; Animals; Bone Matrix; Calcification, Physiologic; Calcium; Cartilage; Chickens; Clodronic Acid; Diphosphates; Diphosphonates; Dose-Response Relationship, Drug; Durapatite; Etidronic Acid; Hydrogen-Ion Concentration; Hydroxyapatites; In Vitro Techniques; Microsomes; Peptide Hydrolases; Phosphorus | 1985 |
Comparison of artificial white spots by microradiography and polarized light microscopy.
Topics: Decalcification Technique; Dental Caries; Dental Enamel; Durapatite; Etidronic Acid; Gels; Humans; Hydroxides; Hydroxyapatites; Lactates; Lactic Acid; Microradiography; Microscopy, Polarization; Potassium; Potassium Compounds | 1984 |
Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation.
Topics: Adenosine Triphosphate; Calcium Phosphates; Citrates; Citric Acid; Durapatite; Etidronic Acid; Foscarnet; Glyceric Acids; Hydroxyapatites; Lasers; Magnesium; Nephelometry and Turbidimetry; Phosphates; Phosphonoacetic Acid; Structure-Activity Relationship | 1982 |
Effectiveness of phosphocitrate and N-sulpho-2-amino tricarballylate, a new analogue of phosphocitrate, in blocking hydroxyapatite induced crystal growth and calcium accumulation by matrix vesicles.
Topics: Animals; Calcium; Cartilage; Chickens; Citrates; Crystallization; Durapatite; Etidronic Acid; Hydroxyapatites; Tricarboxylic Acids | 1984 |
Studies on calcium phosphate precipitation: effects of metal ions used in dental materials.
Topics: Calcium; Calcium Phosphates; Chemical Precipitation; Dental Materials; Durapatite; Etidronic Acid; Hydrogen-Ion Concentration; Metals | 1994 |
Human neutrophil priming: chemiluminescence modified by hydroxyapatite and three bisphosphonates in vitro.
Topics: Adult; Clodronic Acid; Diphosphonates; Durapatite; Etidronic Acid; Humans; Luminescent Measurements; Neutrophil Activation; Neutrophils; Pamidronate; Peroxidase | 1993 |
In vitro and in vivo effects of tetrakisphosphonates on bone resorption, tumor osteolysis, ectopic calcification, and macrophages.
Topics: Animals; Bioprosthesis; Bone Resorption; Calcinosis; Carcinoma 256, Walker; Cell Line; Cell Survival; Diphosphonates; Durapatite; Etidronic Acid; Female; Macrophages; Mice; Osteolysis; Pamidronate; Rats; Rats, Wistar | 1997 |
Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.
Topics: Alkyl and Aryl Transferases; Animals; Bone Density Conservation Agents; Cell Line; Cell Proliferation; Cell Survival; Chromatography, Liquid; Diphosphonates; Durapatite; Etidronic Acid; Geranyltranstransferase; Mice; Organophosphonates; Propionates; Protein Prenylation; Pyridines; Risedronic Acid; Structure-Activity Relationship | 2007 |
188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases.
Topics: Animals; Bone and Bones; Bone Neoplasms; Cattle; Combined Modality Therapy; Deoxycytidine; Diphosphonates; Durapatite; Etidronic Acid; Female; Gemcitabine; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution | 2008 |
Inhibition of the formation of oral calcium phosphate precipitates: the possible effects of certain honeybee products.
Topics: Animals; Bees; Calcium; Calcium Phosphates; Chemical Precipitation; Durapatite; Etidronic Acid; Fructose; Glucose; Honey; Humans; Hydrogen-Ion Concentration; Maltose; Materials Testing; Phosphates; Propolis; Sucrose; Time Factors | 2008 |
The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis.
Topics: Animals; Biomarkers; Biomechanical Phenomena; Bone Density; Bone Density Conservation Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Durapatite; Etidronic Acid; Female; Femur; Humans; Hydroxycholecalciferols; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Wistar; Risedronic Acid; Stress, Mechanical; Treatment Outcome; Weight-Bearing; X-Ray Diffraction; X-Ray Microtomography | 2009 |
Differences between bisphosphonates in binding affinities for hydroxyapatite.
Topics: Bone Density Conservation Agents; Chromatography, Liquid; Diphosphonates; Durapatite; Etidronic Acid; Imidazoles; Risedronic Acid; Spectrophotometry, Ultraviolet; Zoledronic Acid | 2010 |
An in vitro assay to measure targeted drug delivery to bone mineral.
Topics: Alendronate; Anabolic Agents; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Drug Delivery Systems; Durapatite; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Nuclear Magnetic Resonance, Biomolecular; Pamidronate; Risedronic Acid; Zoledronic Acid | 2010 |
Improvement in bone properties by using risedronate adsorbed hydroxyapatite novel nanoparticle based formulation in a rat model of osteoporosis.
Topics: Adsorption; Animals; Biomechanical Phenomena; Bone and Bones; Bone Density; Chemistry, Pharmaceutical; Disease Models, Animal; Durapatite; Etidronic Acid; Femur; Nanoparticles; Osteoporosis; Porosity; Rats; Rats, Wistar; Risedronic Acid; Spectroscopy, Fourier Transform Infrared; Tibia; X-Ray Diffraction | 2013 |
Drug composition matters: the influence of carrier concentration on the radiochemical purity, hydroxyapatite affinity and in-vivo bone accumulation of the therapeutic radiopharmaceutical 188Rhenium-HEDP.
Topics: Animals; Bone and Bones; Durapatite; Etidronic Acid; Male; Mice; Mice, Inbred C57BL; Radiochemistry; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution | 2015 |
Phosphate functionalized (4,4)-armchair CNTs as novel drug delivery systems for alendronate and etidronate anti-osteoporosis drugs.
Topics: Alendronate; Drug Carriers; Drug Delivery Systems; Durapatite; Etidronic Acid; Osteoporosis; Phosphates | 2017 |
Understanding the Protective Effect of Phytate in Bone Decalcification Related-Diseases.
Topics: Absorptiometry, Photon; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Diseases; Cross-Sectional Studies; Diet; Durapatite; Etidronic Acid; Female; Humans; Middle Aged; Phytic Acid; Postmenopause; Prospective Studies; Solubility; Spain | 2021 |
Real-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Diphosphonates; Durapatite; Electric Impedance; Etidronic Acid; Humans; Microbial Sensitivity Tests; Moxifloxacin; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus | 2023 |